Loading...
OTCM
PRTT
Market cap7mUSD
Dec 04, Last price  
0.12USD
1D
-23.56%
1Q
-65.06%
IPO
-65.06%
Name

Protect Pharmaceutical Corporation Inc

Chart & Performance

D1W1MN
OTCM:PRTT chart
P/E
0.12
P/S
0.05
EPS
0.98
Div Yield, %
Shrs. gr., 5y
0.89%
Rev. gr., 5y
%
Revenues
132m
-2.86%
00000000005,940,84378,794,00081,799,000136,158,000132,262,000
Net income
56m
+22.68%
-2,150-7,026,356-270,109-554,298-23,939458,145-635,464-41,707-122,611-1,8735,813,10020,208,00022,442,00045,912,00056,327,000
CFO
4m
P
0022,171-21,411-179-179-17,805-14,1580-36,08611,9756,774,29010,505,000-67,199,0004,042,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Protect Pharmaceutical Corporation primarily focuses on crop farming and agricultural businesses. It acquires the Can Noguera property located in Selva Girona region in Spain. Its property consists of 60 hectares of arable land, 390 hectares of forests, 6 mineral and freshwater wells, and 3000 square meters of built properties. The company was formerly known as Pro-Tect, Inc. and changed its name to Protect Pharmaceutical Corporation in March 2010. Protect Pharmaceutical Corporation was founded in 1987 and is based in Las Vegas, Nevada.
IPO date
Aug 01, 2006
Employees
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT